Further, our data suggest that the anti‐proliferation in CRC cells caused by combining CUR with MET is partially related to the downregulated pAKT/mTOR/Cyclin D1 signaling pathway (Figure 1E,F), likely due to the dysfunction of the iron transporter DMT1. Here, MET is linked to colorectal carcinoma.